María del Mar Maldonado

Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment

María del Mar Maldonado, Jeffrey Schlom, Duane H. Hamilton · Cancer Immunology Immunotherapy · 2023 · 33 citations · Full text

Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer

Luis D. Borrero-García, María del Mar Maldonado, Julia Medina‐Velázquez et al. · BMC Cancer · 2021 · 19 citations · Full text

Characterization of Novel Derivatives of MBQ-167, an Inhibitor of the GTP-binding Proteins Rac/Cdc42

Julia I. Medina, Ailed Cruz‐Collazo, María del Mar Maldonado et al. · Cancer Research Communications · 2022 · 16 citations · Full text

Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167 in Mice by Supercritical Fluid Chromatography–Tandem Mass Spectrometry

María del Mar Maldonado, Gabriela T. Rosado-González, Joseph Bloom et al. · ACS Omega · 2019 · 15 citations · Full text

Pharmaceutical Science, Rac/cdc42 Inhibitor Mbq-167, Supercritical Fluid Chromatography +18

Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice

Javier Reig-López, María del Mar Maldonado, Matilde Merino‐Sanjuán et al. · Pharmaceutics · 2020 · 11 citations · Full text

Dual Inhibitor, Tumor Biology, Physiologically-based Pharmacokinetic/pharmacodynamic Model +14